Fitzgerald S. Lao

540 total citations
27 papers, 425 citations indexed

About

Fitzgerald S. Lao is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Fitzgerald S. Lao has authored 27 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 9 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Fitzgerald S. Lao's work include Immune Response and Inflammation (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Immunotherapy and Immune Responses (6 papers). Fitzgerald S. Lao is often cited by papers focused on Immune Response and Inflammation (10 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Immunotherapy and Immune Responses (6 papers). Fitzgerald S. Lao collaborates with scholars based in United States, Japan and China. Fitzgerald S. Lao's co-authors include Dennis A. Carson, Christina Wu, Thomas J. Kipps, Bing Cui, Shiyin Yao, Tomoko Hayashi, Howard B. Cottam, Maripat Corr, Fumi Sato-Kaneko and Catriona Jamieson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Fitzgerald S. Lao

27 papers receiving 418 citations

Peers

Fitzgerald S. Lao
Sonia Iyer United States
R. Katherine Hyde United States
Qing Tong China
Joshua W. Collins United States
Christelle P El-Haibi United States
Tamara Tripic United States
Sonia Iyer United States
Fitzgerald S. Lao
Citations per year, relative to Fitzgerald S. Lao Fitzgerald S. Lao (= 1×) peers Sonia Iyer

Countries citing papers authored by Fitzgerald S. Lao

Since Specialization
Citations

This map shows the geographic impact of Fitzgerald S. Lao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fitzgerald S. Lao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fitzgerald S. Lao more than expected).

Fields of papers citing papers by Fitzgerald S. Lao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fitzgerald S. Lao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fitzgerald S. Lao. The network helps show where Fitzgerald S. Lao may publish in the future.

Co-authorship network of co-authors of Fitzgerald S. Lao

This figure shows the co-authorship network connecting the top 25 collaborators of Fitzgerald S. Lao. A scholar is included among the top collaborators of Fitzgerald S. Lao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fitzgerald S. Lao. Fitzgerald S. Lao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sako, Y, Fumi Sato-Kaneko, Nikunj M. Shukla, et al.. (2023). Identification of a Novel Small Molecule That Enhances the Release of Extracellular Vesicles with Immunostimulatory Potency via Induction of Calcium Influx. ACS Chemical Biology. 18(4). 982–993. 9 indexed citations
2.
Shukla, Nikunj M., Fumi Sato-Kaneko, Shiyin Yao, et al.. (2022). A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory Activity. Frontiers in Pharmacology. 13. 869649–869649. 7 indexed citations
3.
Sato-Kaneko, Fumi, Shiyin Yao, Fitzgerald S. Lao, et al.. (2022). A Dual Adjuvant System for Intranasal Boosting of Local and Systemic Immunity for Influenza Vaccination. Vaccines. 10(10). 1694–1694. 4 indexed citations
4.
Shukla, Nikunj M., Michael Chan, Fitzgerald S. Lao, et al.. (2021). Structure-activity relationship studies in substituted sulfamoyl benzamidothiazoles that prolong NF-κB activation. Bioorganic & Medicinal Chemistry. 43. 116242–116242. 7 indexed citations
5.
Lao, Fitzgerald S., Shiyin Yao, Chenyang Li, et al.. (2021). Generation and Application of a Reporter Cell Line for the Quantitative Screen of Extracellular Vesicle Release. Frontiers in Pharmacology. 12. 668609–668609. 22 indexed citations
6.
Saito, Tetsuya, Y Sako, Fumi Sato-Kaneko, et al.. (2021). Small Molecule Potentiator of Adjuvant Activity Enhancing Survival to Influenza Viral Challenge. Frontiers in Immunology. 12. 701445–701445. 4 indexed citations
7.
Sato-Kaneko, Fumi, Shiyin Yao, Fitzgerald S. Lao, et al.. (2021). Mitochondria-dependent synthetic small-molecule vaccine adjuvants for influenza virus infection. Proceedings of the National Academy of Sciences. 118(23). 9 indexed citations
8.
Hosoya, Tadashi, Nikunj M. Shukla, Shiyin Yao, et al.. (2020). Identification of Compounds With Glucocorticoid Sparing Effects on Suppression of Chemokine and Cytokine Production by Rheumatoid Arthritis Fibroblast-Like Synoviocytes. Frontiers in Pharmacology. 11. 607713–607713. 3 indexed citations
9.
Sato-Kaneko, Fumi, Shiyin Yao, Fitzgerald S. Lao, et al.. (2020). A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity. Frontiers in Immunology. 11. 1207–1207. 23 indexed citations
10.
Chan, Michael, Fitzgerald S. Lao, Shiyin Yao, et al.. (2019). Structure–Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune Stimuli. Journal of Medicinal Chemistry. 62(21). 9521–9540. 9 indexed citations
11.
Shukla, Nikunj M., Kei‐ichiro Arimoto, Shiyin Yao, et al.. (2018). Identification of Compounds That Prolong Type I Interferon Signaling as Potential Vaccine Adjuvants. SLAS DISCOVERY. 23(9). 960–973. 10 indexed citations
12.
Sato-Kaneko, Fumi, Xiaodong Wang, Shiyin Yao, et al.. (2018). Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer Immunotherapy. BioMed Research International. 2018. 1–13. 11 indexed citations
13.
Hosoya, Tadashi, Fumi Sato-Kaneko, Shiyin Yao, et al.. (2018). Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist. Proceedings of the National Academy of Sciences. 115(29). E6836–E6844. 22 indexed citations
14.
Wu, Christina, Ekaterina V. Vinogradova, Fitzgerald S. Lao, et al.. (2017). Proteomic Analysis Reveals IRAK4 As a Therapeutic Target in Chronic Lymphocytic Leukemia. Blood. 130. 3838–3838. 1 indexed citations
15.
Wu, Christina, Fitzgerald S. Lao, Hongying Li, et al.. (2016). Inhibition of Casein Kinase 2 Impairs Wnt Signaling and Cell Survival in Chronic Lymphocytic Leukemia. Blood. 128(22). 2050–2050. 3 indexed citations
16.
Wu, Christina, Fitzgerald S. Lao, Hongying Li, et al.. (2014). Inhibition of Wnt Signaling By Dimethyl Fumarate Results in in Vitro and in Vivo Clearance of Chronic Lymphocytic Leukemia Cells and Has Additive Activity with Ibrutinib. Blood. 124(21). 4683–4683. 3 indexed citations
17.
Wu, Christina, Brian Crain, Shiyin Yao, et al.. (2013). Innate Immune Protection against Infectious Diseases by Pulmonary Administration of a Phospholipid-Conjugated TLR7 Ligand. Journal of Innate Immunity. 6(3). 315–324. 18 indexed citations
18.
Zhang, Suping, Christina Wu, Jessie-F. Fecteau, et al.. (2013). Targeting chronic lymphocytic leukemia cells with a humanized monoclonal antibody specific for CD44. Proceedings of the National Academy of Sciences. 110(15). 6127–6132. 87 indexed citations
19.
Cui, Bing, George F. Widhopf, Charles Prussak, et al.. (2013). Cirmtuzumab Vedotin (UC-961ADC3), An Anti-ROR1-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment For ROR1-Positive Leukemia and Solid Tumors. Blood. 122(21). 1637–1637. 11 indexed citations
20.
Hayashi, Tomoko, Shiyin Yao, Brian Crain, et al.. (2012). Treatment of Autoimmune Inflammation by a TLR7 Ligand Regulating the Innate Immune System. PLoS ONE. 7(9). e45860–e45860. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026